-Search query
-Search result
Showing 1 - 50 of 126 items for (author: moriya & t)

EMDB-62652: 
The cryo-EM structure of porcine serum MGAM
Method: single particle / : Tagami T, Kawasaki M, Adachi N

EMDB-62653: 
The cryo-EM structure of porcine serum MGAM bound with Acarviosyl-maltotriose.
Method: single particle / : Tagami T, Kawasaki M, Adachi N

EMDB-64381: 
Cryo-EM structure of pyrene-modified TIP60 double mutant (G12C/S50C) with addition of Nile Red
Method: single particle / : Yamashita M, Kawakami N, Arai R, Ikeda A, Moriya T, Senda T, Miyamoto K

PDB-9uol: 
Cryo-EM structure of pyrene-modified TIP60 double mutant (G12C/S50C) with addition of Nile Red
Method: single particle / : Yamashita M, Kawakami N, Arai R, Ikeda A, Moriya T, Senda T, Miyamoto K

EMDB-65631: 
Subtomogram average of MJ1HA S-layer
Method: subtomogram averaging / : Goto-Ito S, Yamagata A, Lee Y, Ehara H, Ito T

EMDB-65632: 
Subtomogram average of MJ1 attachment organelle
Method: subtomogram averaging / : Goto-Ito S, Yamagata A, Lee Y, Ehara H, Ito T

EMDB-60989: 
Class 2 state of the GfsA KSQ-ancestralAT chimeric didomain in complex with the GfsA ACP domain
Method: single particle / : Chisuga T, Liao Z, Adachi N, Kawasaki M, Moriya T, Senda T, Kudo F, Eguchi T, Miyanaga A

EMDB-61520: 
Class 3 state of the GfsA KSQ-ancestralAT chimeric didomain in complex with the GfsA ACP domain
Method: single particle / : Chisuga T, Liao Z, Adachi N, Kawasaki M, Moriya T, Senda T, Kudo F, Eguchi T, Miyanaga A

EMDB-61522: 
Class 1 state of the GfsA KSQ-ancestralAT chimeric didomain in complex with the GfsA ACP domain
Method: single particle / : Chisuga T, Liao Z, Adachi N, Kawasaki M, Moriya T, Senda T, Kudo F, Eguchi T, Miyanaga A

PDB-9jj9: 
Class 3 state of the GfsA KSQ-ancestralAT chimeric didomain in complex with the GfsA ACP domain
Method: single particle / : Chisuga T, Liao Z, Adachi N, Kawasaki M, Moriya T, Senda T, Kudo F, Eguchi T, Miyanaga A

PDB-9jjb: 
Class 1 state of the GfsA KSQ-ancestralAT chimeric didomain in complex with the GfsA ACP domain
Method: single particle / : Chisuga T, Liao Z, Adachi N, Kawasaki M, Moriya T, Senda T, Kudo F, Eguchi T, Miyanaga A

EMDB-37440: 
Cryo-EM structure of the inhibitor-bound Vo complex from Enterococcus hirae
Method: single particle / : Suzuki K, Mikuriya S, Adachi N, Kawasaki M, Senda T, Moriya T, Murata T

PDB-8wci: 
Cryo-EM structure of the inhibitor-bound Vo complex from Enterococcus hirae
Method: single particle / : Suzuki K, Mikuriya S, Adachi N, Kawasaki M, Senda T, Moriya T, Murata T

EMDB-60573: 
Cryo-EM Structure of inhibitor-free hERG Channel
Method: single particle / : Miyashita Y, Moriya T, Kato T, Kawasaki M, Yasuda Y, Adachi N, Suzuki K, Ogasawara S, Saito T, Senda T, Murata T

EMDB-60574: 
Cryo-EM Structure of astemizole-bound hERG Channel
Method: single particle / : Miyashita Y, Moriya T, Kato T, Kawasaki M, Yasuda Y, Adachi N, Suzuki K, Ogasawara S, Saito T, Senda T, Murata T

EMDB-60575: 
Cryo-EM Structure of E-4031-bound hERG Channel
Method: single particle / : Miyashita Y, Moriya T, Kato T, Kawasaki M, Yasuda Y, Adachi N, Suzuki K, Ogasawara S, Saito T, Senda T, Murata T

EMDB-60576: 
Cryo-EM Structure of pimozide-bound hERG Channel
Method: single particle / : Miyashita Y, Moriya T, Kato T, Kawasaki M, Yasuda Y, Adachi N, Suzuki K, Ogasawara S, Saito T, Senda T, Murata T

PDB-8zyn: 
Cryo-EM Structure of inhibitor-free hERG Channel
Method: single particle / : Miyashita Y, Moriya T, Kato T, Kawasaki M, Yasuda Y, Adachi N, Suzuki K, Ogasawara S, Saito T, Senda T, Murata T

PDB-8zyo: 
Cryo-EM Structure of astemizole-bound hERG Channel
Method: single particle / : Miyashita Y, Moriya T, Kato T, Kawasaki M, Yasuda Y, Adachi N, Suzuki K, Ogasawara S, Saito T, Senda T, Murata T

PDB-8zyp: 
Cryo-EM Structure of E-4031-bound hERG Channel
Method: single particle / : Miyashita Y, Moriya T, Kato T, Kawasaki M, Yasuda Y, Adachi N, Suzuki K, Ogasawara S, Saito T, Senda T, Murata T

PDB-8zyq: 
Cryo-EM Structure of pimozide-bound hERG Channel
Method: single particle / : Miyashita Y, Moriya T, Kato T, Kawasaki M, Yasuda Y, Adachi N, Suzuki K, Ogasawara S, Saito T, Senda T, Murata T

EMDB-38986: 
P-glycoprotein in complex with UIC2 Fab and triple elacridar molecules in LMNG detergent
Method: single particle / : Hamaguchi-Suzuki N, Adachi N, Moriya T, Kawasaki M, Suzuki K, Anzai N, Senda T, Murata T

EMDB-38987: 
P-glycoprotein in complex with UIC2 Fab and triple elacridar molecules in nanodisc
Method: single particle / : Hamaguchi-Suzuki N, Adachi N, Moriya T, Kawasaki M, Suzuki K, Anzai N, Senda T, Murata T

PDB-8y6h: 
P-glycoprotein in complex with UIC2 Fab and triple elacridar molecules in LMNG detergent
Method: single particle / : Hamaguchi-Suzuki N, Adachi N, Moriya T, Kawasaki M, Suzuki K, Anzai N, Senda T, Murata T

PDB-8y6i: 
P-glycoprotein in complex with UIC2 Fab and triple elacridar molecules in nanodisc
Method: single particle / : Hamaguchi-Suzuki N, Adachi N, Moriya T, Kawasaki M, Suzuki K, Anzai N, Senda T, Murata T

EMDB-34741: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-11
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-34742: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-11 focused on RBD and NIV-11 interface
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

PDB-8hgl: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-11
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

PDB-8hgm: 
Structure of SARS-CoV-2 spike RBD in complex with neutralizing antibody NIV-11
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33820: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-8 focused on RBD and NIV-8 interface
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33821: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-8 (state 1)
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33822: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-8 (state 2)
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33823: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-10 focused on RBD and NIV-10 interface
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33824: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-10 (state 1)
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33825: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-10 (state 2)
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33826: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-10 (state 3)
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33827: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-13 focused on RBD and NIV-13 interface
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33828: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-13 (state 1)
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33829: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-13 (state 2)
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33830: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-13 (state 3)
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

PDB-7yh6: 
Structure of SARS-CoV-2 spike RBD in complex with neutralizing antibody NIV-8
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

PDB-7yh7: 
SARS-CoV-2 spike in complex with neutralizing antibody NIV-8 (state 2)
Method: single particle / : Moriyama S, Anraku Y, Muranishi S, Adachi Y, Kuroda D, Higuchi Y, Kotaki R, Tonouchi K, Yumoto K, Suzuki T, Kita S, Someya T, Fukuhara H, Kuroda Y, Yamamoto T, Onodera T, Fukushi S, Maeda K, Nakamura-Uchiyama F, Hashiguchi T, Hoshino A, Maenaka K, Takahashi Y

EMDB-33643: 
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab816
Method: single particle / : Uchikubo T, Shirouzu M

EMDB-33644: 
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab803
Method: single particle / : Uchikubo T, Shirouzu M

PDB-7y6l: 
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab816
Method: single particle / : Uchikubo T, Shirouzu M

PDB-7y6n: 
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab803
Method: single particle / : Uchikubo T, Shirouzu M

EMDB-33065: 
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab765
Method: single particle / : Kamada K, Shirouzu M

EMDB-33066: 
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab712
Method: single particle / : Kamada K, Shirouzu M

EMDB-33067: 
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab709
Method: single particle / : Kamada K, Shirouzu M

EMDB-33068: 
The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab847
Method: single particle / : Kamada K, Shirouzu M
Pages:
Movie
Controller
Structure viewers
About EMN search



wwPDB to switch to version 3 of the EMDB data model
